Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population

被引：0
|
作者：
David M. Kern
Lawrence Chang
Kalyani Sonawane
Cynthia J. Larmore
Natalie N. Boytsov
Ralph A. Quimbo
Joseph Singer
John T. Hinton
Sze-jung Wu
Andre B. Araujo
机构：
[1] HealthCore,
[2] Inc,undefined
[3] Eli Lilly and Company,undefined
[4] Anthem,undefined
[5] Inc,undefined
来源：
Rheumatology and Therapy | 2018年 / 5卷
关键词：
Arthritis; Antirheumatic agents; Guideline adherence; Medication adherence; Practice patterns; Physicians’ rheumatoid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：355 / 369
页数：14
相关论文
共 50 条
  • [1] Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population
    Kern, David M.
    Chang, Lawrence
    Sonawane, Kalyani
    Larmore, Cynthia J.
    Boytsov, Natalie N.
    Quimbo, Ralph A.
    Singer, Joseph
    Hinton, John T.
    Wu, Sze-jung
    Araujo, Andre B.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 355 - 369
  • [2] INITIAL TREATMENT PATTERNS FOR NEWLY DIAGNOSED, COMMERCIALLY INSURED PATIENTS WITH PSORIASIS
    Panattoni, L.
    Hernandez, J.
    Liu, Y.
    Sacks, N.
    Higham, R.
    Stephenson, B.
    Armstrong, A. W.
    VALUE IN HEALTH, 2022, 25 (07) : S595 - S595
  • [3] TREATMENT PATTERNS AMONG PATIENTS DIAGNOSED WITH ADVANCED MELANOMA IN A COMMERCIALLY INSURED POPULATION
    Atkins, M.
    Gupte-Singh, K.
    Stafkey-Mailey, D.
    Yue, B.
    Rao, S.
    VALUE IN HEALTH, 2017, 20 (05) : A124 - A124
  • [4] Evaluation of treatment patterns and disparities in commercially insured patients newly-diagnosed with breast cancer
    Short, L. J.
    Fisher, M. D.
    Wahl, P.
    Kelly, M.
    White, S.
    Rodriguez, N. A.
    Lawless, G. D.
    Brawley, O. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] The impact of rheumatoid arthritis on the commercially insured population in the US
    Kessler, R.
    Petukhova, M.
    Maclean, R.
    Li, T.
    Stang, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 266 - 266
  • [6] RETROSPECTIVE ANALYSIS OF INFLIXIMAB DOSING AND INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A COMMERCIALLY-INSURED POPULATION
    Carter, C.
    Tang, B.
    Changolkar, A.
    McKenzie, R. S.
    Piech, C. T.
    VALUE IN HEALTH, 2009, 12 (03) : A73 - A73
  • [7] Cost and Effectiveness of Biologics for Rheumatoid Arthritis in a Commercially Insured Population
    Curtis, Jeffrey R.
    Chastek, Benjamin
    Becker, Laura
    Quach, Caroleen
    Harrison, David J.
    Yun, Huifeng
    Joseph, George J.
    Collier, David H.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (04): : 318 - 318
  • [8] TREATMENT PERSISTENCE WITH COMBINATION VERSUS MONOTHERAPY IN COMMERCIALLY INSURED PATIENTS WITH RHEUMATOID ARTHRITIS
    Shah, N.
    Bonafede, M. M.
    Chastek, B.
    Thomson, E.
    Song, R.
    Harrison, D. J.
    VALUE IN HEALTH, 2014, 17 (03) : A50 - A50
  • [9] Use Of Oral and Subcutaneous MTX In a Commercially Insured Rheumatoid Arthritis Population
    Curtis, Jeffrey R.
    Xie, Fenglong
    Zhang, Jie
    Chen, Lang
    Yun, Huifeng
    Schiff, Michael H.
    Beukelman, Timothy
    Ginsberg, Seth
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S450 - S450
  • [10] Patterns of Glucocorticoid Use and Provider-Level Variation in a Commercially Insured Incident Rheumatoid Arthritis Population
    Wallace, Beth
    Lin, Paul
    Kamdar, Neil
    Noureldin, Mohamed
    Hayward, Rodney
    Fox, David A.
    Curtis, Jeffrey R.
    Saag, Kenneth
    Wajee, Akbar
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345